GALDERMA RESEARCH & DEVELOPMENT;UNIVERSITAT MUNSTER
发明人:
AUBERT, JEROME,STEINHOFF, MARTIN
申请号:
CA2822723
公开号:
CA2822723A1
申请日:
2011.12.19
申请国别(地区):
CA
年份:
2012
代理人:
摘要:
An in vitro method of screening of candidate compounds for the preventive or curative treatment of rosacea includes determination of the capacity of a compound to modulate the expression or activity of the Transient Receptor Potential cation channel, subfamily A, member 1(TRPA1), as well as the use of modulators of the expression or activity of this transcription factor for the treatment of rosacea; such method also includes in vitro diagnosis or prognosis of this pathology.